Percutaneous decannulation of extracorporeal membrane oxygenation using MANTA device: A real-world single-center experience

Table 1 Baseline and per-procedural characteristics of patients undergoing venoarterial extracorporeal membrane oxygenation decannulation with MANTA vascular closure device

Items	Overall (n = 19)
Age (years)
Mean (SD)	56.8 (13.6)
Median (Min, Max)	56.0 (31.0, 83.0)
Sex, n (%)
Male	12 (63.2)
Female	7 (36.8)
BMI
Mean (SD)	29.0 (5.43)
Median (Min, Max)	29.0 (19.1, 42.6)
Smoking, n (%)
Never	11 (57.9)
Former	4 (21.1)
Active	4 (21.1)
HTN, n (%)
Yes	11 (57.9)
No	8 (42.1)
Diabetes, n (%)
Yes	8 (42.1)
No	11 (57.9)
CAD, n (%)
Yes	15 (78.9)
No	4 (21.1)
Total duration of ECMO (days)
Mean (SD)	6.79 (4.20)
Median (Min, Max)	5.00 (2.00, 20.0)
ECMO indication, n (%)
ACS	7 (36.8)
Cardiac arrest	4 (21.1)
Cardiogenic shock	4 (21.1)
Postcardiotomy	2 (10.5)
TAVI	2 (10.5)
Length of ICU stay (days)
Mean (SD)	18.8 (8.42)
Median (Min, Max)	19.0 (5.00, 43.0)
Arterial cannula size (Fr), n (%)
17	9 (47.4)
18	1 (5.3)
19	8 (42.1)
21	1 (5.3)
Manta size (Fr), n (%)
14	2 (10.5)
18	17 (89.5)
Hb prior to decanulation
Mean (SD)	8.85 (1.12)
Median (Min, Max)	8.50 (7.50, 12.5)
Platelets prior to decanualtion
Mean (SD)	106 (67.9)
Median (Min, Max)	90.0 (38.0, 336)
INR prior to decanulation
Mean (SD)	1.23 (0.338)
Median (Min, Max)	1.20 (0.900, 2.50)

BMI: Body mass index; HTN: Hypertension; CAD: Coronary artery disease; ECMO: Extracorporeal membrane oxygenation; ACS: Acute coronary syndrome; ICU: Intensive care unit; Hb: Hemoglobin; INR: International normalized ratio.